Siemens Healthineers AG (LTS:0PMJ) Operating Income: €3,240 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0PMJ Siemens Healthineers AG LTS:0PMJ
79 GF Score
Price €39.06
GF Value €51.07
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Siemens Healthineers AG Operating Income?

Siemens Healthineers AG LTS:0PMJ +5.97% 79 Operating Income is €3,240 Mil as of Jun. 2026. GuruFocus rates LTS:0PMJ with a GF Score™ of 79/100 and a GF Value™ of €51.07 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Siemens Healthineers AG's Operating Income for the three months ended in Jun. 2026 was €946 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Jun. 2026 was €3,240 Mil.

Operating Margin % is calculated as Operating Income divided by its Revenue. Siemens Healthineers AG's Operating Income for the three months ended in Jun. 2026 was €946 Mil. Siemens Healthineers AG's Revenue for the three months ended in Jun. 2026 was €5,764 Mil. Therefore, Siemens Healthineers AG's Operating Margin % for the quarter that ended in Jun. 2026 was 16.41%.

Warning Sign:

Siemens Healthineers AG operating margin has been in a 5-year decline. The average rate of decline per year is -1.9%.

Siemens Healthineers AG's 5-Year average Growth Rate for Operating Margin % was -1.90% per year.

Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Siemens Healthineers AG's annualized ROC % for the quarter that ended in Jun. 2026 was 7.81%. Siemens Healthineers AG's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2026 was 80.18%.


Siemens Healthineers AG  (LTS:0PMJ) Operating Income Explanation

1. Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Siemens Healthineers AG's annualized ROC % for the quarter that ended in Jun. 2026 is calculated as:

ROC % (Q: Jun. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Mar. 2026 ) + Invested Capital (Q: Jun. 2026 ))/ count )
=3784 * ( 1 - 22.92% )/( (37152 + 37564)/ 2 )
=2916.7072/37358
=7.81 %

where

Note: The Operating Income data used here is four times the quarterly (Jun. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Siemens Healthineers AG's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Jun. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Mar. 2026  Q: Jun. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=3920/( ( (4840 + max(-2594, 0)) + (4938 + max(-2463, 0)) )/ 2 )
=3920/( ( 4840 + 4938 )/ 2 )
=3920/4889
=80.18 %

where Working Capital is:

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(4585 + 4463 + 925) - (6368 + 0 + 6199)
=-2594

Working Capital(Q: Jun. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(4515 + 4723 + 917) - (6098 + 0 + 6520)
=-2463

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Jun. 2026) EBIT data.

3. Operating Income is also linked to Operating Margin %:

Siemens Healthineers AG's Operating Margin % for the quarter that ended in Jun. 2026 is calculated as:

Operating Margin %=Operating Income (Q: Jun. 2026 )/Revenue (Q: Jun. 2026 )
=946/5764
=16.41 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

4. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Operating Income growth rate using Operating Income per share data.


Be Aware

Compared with a company's EBITDA margin, Operating Margin can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin may decline. Often the Operating Margin declines well before the company's revenue or even profit decline. Therefore, Operating Margin is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia's Operating Margin had already been in decline since 2002, although its earnings per share were still rising. Investors who paid attention to Operating Margin would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Siemens Healthineers AG Operating Income Related Terms


Siemens Healthineers AG Operating Income Historical Data

* Premium members only.

The historical data trend for Siemens Healthineers AG's Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Siemens Healthineers AG Operating Income Chart

Siemens Healthineers AG Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Operating Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,568.00 2,924.00 2,133.00 2,809.00 3,164.00

Siemens Healthineers AG Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Operating Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 732.00 892.00 677.00 725.00 946.00
LTS:0PMJ
79GF Score
Siemens Healthineers AG LTS:0PMJ
Operating Income is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Siemens Healthineers AG Operating Income Calculation

Operating Income, is the profit a company earned through operations. All expenses, including cash expenses such as cost of goods sold (COGS), research & development, wages, and non-cash expenses, such as depreciation, depletion and amortization, have been deducted from the sales.

Operating Income for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €3,240 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Operating Income →
What does a Operating Income of €3,240 Mil mean?
Siemens Healthineers AG (LTS:0PMJ) has a Operating Income of €3,240 Mil as of Jun. 2026. Operating Income equals sales less all operating expenses. It is linked to EBIT. View historical data on Siemens Healthineers AG and its competitors.
Is Siemens Healthineers AG's Operating Income too high?
Siemens Healthineers AG's current Operating Income is €3,240 Mil. Overall, Siemens Healthineers AG has a GF Score™ of 79/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Siemens Healthineers AG's Operating Income compare to ABT and SYK?
Siemens Healthineers AG's Operating Income of €3,240 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Income for a Medical Devices & Instruments company?
A good Operating Income depends on the Medical Devices & Instruments industry context. However, Operating Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Income mean?
A high Operating Income can signal that a stock is expensive relative to its fundamentals. Operating Income equals sales less all operating expenses. It is linked to EBIT. View historical data on Siemens Healthineers AG and its competitors. Siemens Healthineers AG's current Operating Income is €3,240 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Siemens Healthineers AG stock overvalued right now?
Based on GuruFocus' analysis, Siemens Healthineers AG (LTS:0PMJ) is currently considered Modestly Undervalued. The stock's GF Value™ is €51.07, compared to a current price of €39.06 — trading 23.5% below its estimated fair value. The current Operating Income is €3,240 Mil. Siemens Healthineers AG's overall GF Score™ is 79/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Income calculated?
Operating Income is calculated from a company's financial statements. For Siemens Healthineers AG (LTS:0PMJ), the current Operating Income is €3,240 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Siemens Healthineers AG (LTS:0PMJ) Overvalued in 2026?

Based on GuruFocus' analysis, Siemens Healthineers AG stock appears to be undervalued. The current stock price of €39.06 is trading 23.5% below its estimated GF Value™ of €51.07. GuruFocus considers Siemens Healthineers AG to be Modestly Undervalued.

Key valuation signals for LTS:0PMJ:

  • Operating Income: €3,240 Mil
  • GF Value™: €51.07 vs. price of €39.06 (23.5% below fair value)
  • GF Score™: 79/100 with 4 warning signs

No single metric tells the full story. See the LTS:0PMJ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Siemens Healthineers AG Business Description

Address Siemensstrasse 3, Forchheim, BY, DEU, 91301
Siemens Healthineers is engaged in therapeutic imaging, radiotherapy, laboratory, and point-of-care diagnostics. The imaging segment (56% of sales in fiscal 2025) includes magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound. The Varian segment (18% of sales) offers radiotherapy and other oncology solutions. The diagnostics segment (19%) includes in vitro diagnostics and point-of-care diagnostics. The advanced therapies (now part of precision therapy) segment (9%) products are designed to support image-guided minimally invasive treatments in cardiology, interventional radiology, and surgery. The Americas represents 44% of total sales, Europe, Middle East, and Africa 32%, and Asia-Pacific, including China (11%), the remainder.
79GF Score

Get the complete analysis for LTS:0PMJ

Operating Income is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€39.06
Price
€51.07
GF Value